Published • loading... • Updated
Research and New Therapies, the Challenge of Accessing Treatment. Murzi (J&J): “Innovation Is Such only if It Is Accessible to Patients”
Summary by quotidianosanita.it
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
For the CEO of Johnson&Johnson Innovative Medicine Italia, health must increasingly be considered an investment and not a cost. In addition, to strengthen Italy's competitiveness, more favorable conditions for investments and a more predictive environment are needed. And on payback: “A handbrake” that makes it difficult to plan long-term investments The post Research and new therapies, the challenge of accessing treatment. Murzi (J&J): “Innovati…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
